---
document_datetime: 2025-11-23 08:01:05
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/paxene.html
document_name: paxene.html
version: success
processing_time: 0.0949705
conversion_datetime: 2025-12-25 05:16:58.56306
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Paxene

[RSS](/en/individual-human-medicine.xml/66851)

##### Withdrawn

This medicine's authorisation has been withdrawn

paclitaxel

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 19 July 1999 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Paxene.

The marketing authorisation holder (MAH) responsible for Paxene was Norton Healthcare Limited. The European Commission was notified by letter dated 26 October 2009 of the MAH's decision to voluntarily withdraw the marketing authorisation as of 1 March 2010 for Paxene for commercial reasons. Paxene was only marketed in France.

On 26 November 2009 the European Commission issued a decision to withdraw the marketing authorisation for Paxene.

Pursuant to this decision the European Public Assessment Report for Paxene is updated to reflect that the marketing authorisation is no longer valid.

Paxene : EPAR - Summary for the public

English (EN) (265.36 KB - PDF)

**First published:** 13/08/2009

**Last updated:** 22/03/2010

[View](/en/documents/overview/paxene-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-936)

български (BG) (428.95 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/bg/documents/overview/paxene-epar-summary-public_bg.pdf)

español (ES) (267.24 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/es/documents/overview/paxene-epar-summary-public_es.pdf)

čeština (CS) (401.66 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/cs/documents/overview/paxene-epar-summary-public_cs.pdf)

dansk (DA) (266.71 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/da/documents/overview/paxene-epar-summary-public_da.pdf)

Deutsch (DE) (271.54 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/de/documents/overview/paxene-epar-summary-public_de.pdf)

eesti keel (ET) (265.44 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/et/documents/overview/paxene-epar-summary-public_et.pdf)

ελληνικά (EL) (463.53 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/el/documents/overview/paxene-epar-summary-public_el.pdf)

français (FR) (270.97 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/fr/documents/overview/paxene-epar-summary-public_fr.pdf)

italiano (IT) (266.75 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/it/documents/overview/paxene-epar-summary-public_it.pdf)

latviešu valoda (LV) (407.86 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/lv/documents/overview/paxene-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (381.21 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/lt/documents/overview/paxene-epar-summary-public_lt.pdf)

magyar (HU) (390.99 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/hu/documents/overview/paxene-epar-summary-public_hu.pdf)

Malti (MT) (399.29 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/mt/documents/overview/paxene-epar-summary-public_mt.pdf)

Nederlands (NL) (270.49 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/nl/documents/overview/paxene-epar-summary-public_nl.pdf)

polski (PL) (422.53 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/pl/documents/overview/paxene-epar-summary-public_pl.pdf)

português (PT) (270.85 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/pt/documents/overview/paxene-epar-summary-public_pt.pdf)

română (RO) (374.76 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/ro/documents/overview/paxene-epar-summary-public_ro.pdf)

slovenčina (SK) (398.08 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/sk/documents/overview/paxene-epar-summary-public_sk.pdf)

slovenščina (SL) (357.62 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/sl/documents/overview/paxene-epar-summary-public_sl.pdf)

Suomi (FI) (265.89 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/fi/documents/overview/paxene-epar-summary-public_fi.pdf)

svenska (SV) (285.08 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/sv/documents/overview/paxene-epar-summary-public_sv.pdf)

## Product information

Paxene : EPAR - Product Information

English (EN) (711.22 KB - PDF)

**First published:** 13/08/2009

**Last updated:** 22/03/2010

[View](/en/documents/product-information/paxene-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-583)

български (BG) (1.64 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/bg/documents/product-information/paxene-epar-product-information_bg.pdf)

español (ES) (741.4 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/es/documents/product-information/paxene-epar-product-information_es.pdf)

čeština (CS) (1.18 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/cs/documents/product-information/paxene-epar-product-information_cs.pdf)

dansk (DA) (733.62 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/da/documents/product-information/paxene-epar-product-information_da.pdf)

Deutsch (DE) (738.17 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/de/documents/product-information/paxene-epar-product-information_de.pdf)

eesti keel (ET) (724.39 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/et/documents/product-information/paxene-epar-product-information_et.pdf)

ελληνικά (EL) (1.65 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/el/documents/product-information/paxene-epar-product-information_el.pdf)

français (FR) (733.44 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/fr/documents/product-information/paxene-epar-product-information_fr.pdf)

italiano (IT) (725.19 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/it/documents/product-information/paxene-epar-product-information_it.pdf)

latviešu valoda (LV) (457.18 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/lv/documents/product-information/paxene-epar-product-information_lv.pdf)

lietuvių kalba (LT) (812.6 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/lt/documents/product-information/paxene-epar-product-information_lt.pdf)

magyar (HU) (1.18 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/hu/documents/product-information/paxene-epar-product-information_hu.pdf)

Malti (MT) (1.23 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/mt/documents/product-information/paxene-epar-product-information_mt.pdf)

Nederlands (NL) (721.84 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/nl/documents/product-information/paxene-epar-product-information_nl.pdf)

polski (PL) (1.25 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/pl/documents/product-information/paxene-epar-product-information_pl.pdf)

português (PT) (718.7 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/pt/documents/product-information/paxene-epar-product-information_pt.pdf)

română (RO) (862.21 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/ro/documents/product-information/paxene-epar-product-information_ro.pdf)

slovenčina (SK) (1.18 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/sk/documents/product-information/paxene-epar-product-information_sk.pdf)

slovenščina (SL) (1.14 MB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/sl/documents/product-information/paxene-epar-product-information_sl.pdf)

Suomi (FI) (726.6 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/fi/documents/product-information/paxene-epar-product-information_fi.pdf)

svenska (SV) (701.76 KB - PDF)

**First published:**

13/08/2009

**Last updated:**

22/03/2010

[View](/sv/documents/product-information/paxene-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** R/0047 14/07/2009

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Paxene : EPAR - All Authorised presentations

English (EN) (271.68 KB - PDF)

**First published:** 15/12/2005

**Last updated:** 22/03/2010

[View](/en/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-363)

български (BG) (315.69 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/bg/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_bg.pdf)

español (ES) (272.5 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/es/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_es.pdf)

čeština (CS) (304.81 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/cs/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (276.51 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/da/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (277.16 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/de/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (272.13 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/et/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (312.73 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/el/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_el.pdf)

français (FR) (273.83 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/fr/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (271.34 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/it/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (306.66 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/lv/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (294.88 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/lt/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (295.29 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/hu/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (240.95 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/mt/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (273.23 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/nl/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_nl.pdf)

polski (PL) (308.15 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/pl/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_pl.pdf)

português (PT) (272.79 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/pt/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_pt.pdf)

română (RO) (292.87 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/ro/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (304.6 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/sk/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (285.19 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/sl/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (271.45 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/fi/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (274.71 KB - PDF)

**First published:**

15/12/2005

**Last updated:**

22/03/2010

[View](/sv/documents/all-authorised-presentations/paxene-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Paxene Active substance paclitaxel International non-proprietary name (INN) or common name paclitaxel Therapeutic area (MeSH)

- Sarcoma, Kaposi
- Carcinoma, Non-Small-Cell Lung
- Ovarian Neoplasms
- Breast Neoplasms

Anatomical therapeutic chemical (ATC) code L01CD01

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

Paxene is indicated for the treatment of patients with:

- advanced AIDS-related Kaposi's sarcoma (AIDS-KS) who have failed prior liposomal anthracycline therapy;
- metastatic carcinoma of the breast (MBC) who have failed, or are not candidates for standard anthracycline-containing therapy;
- advanced carcinoma of the ovary (AOC) or with residual disease (&gt; 1 cm) after initial laparotomy, in combination with cisplatin as first-line treatment;
- metastatic carcinoma of the ovary (MOC) after failure of platinum-containing combination therapy without taxanes as second-line treatment;
- non-small cell lung carcinoma (NSCLC) who are not candidates for potentially curative surgery and/or radiation therapy, in combination with cisplatin. Limited efficacy data supports this indication (see section 5.1).

## Authorisation details

EMA product number EMEA/H/C/000216 Marketing authorisation holder

Norton Healthcare Ltd.

Norton Healthcare Limited

Marketing authorisation issued 19/07/1999 Withdrawal of marketing authorisation 01/03/2010 Revision 14

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Paxene : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (274.22 KB - PDF)

**First published:** 12/08/2009

**Last updated:** 22/03/2010

[View](/en/documents/procedural-steps-after/paxene-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Paxene-H-C-399-II-26 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (547.41 KB - PDF)

**First published:** 15/12/2005

**Last updated:** 22/03/2010

[View](/en/documents/scientific-discussion-variation/paxene-h-c-399-ii-26-epar-scientific-discussion-variation_en.pdf)

Paxene : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (320.57 KB - PDF)

**First published:** 15/12/2005

**Last updated:** 22/03/2010

[View](/en/documents/steps-after-cutoff/paxene-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

Paxene-H-C-399-II-25 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (423.93 KB - PDF)

**First published:** 15/12/2005

**Last updated:** 22/03/2010

[View](/en/documents/scientific-discussion-variation/paxene-h-c-399-ii-25-epar-scientific-discussion-variation_en.pdf)

## Initial marketing authorisation documents

Paxene : EPAR - Procedural steps taken before authorisation

English (EN) (309.16 KB - PDF)

**First published:** 15/12/2005

**Last updated:** 22/03/2010

[View](/en/documents/procedural-steps/paxene-epar-procedural-steps-taken-authorisation_en.pdf)

Paxene : EPAR - Scientific Discussion

English (EN) (682.5 KB - PDF)

**First published:** 15/12/2005

**Last updated:** 22/03/2010

[View](/en/documents/scientific-discussion/paxene-epar-scientific-discussion_en.pdf)

**This page was last updated on** 22/03/2010

## Share this page

[Back to top](#main-content)